in our hospital. Patients whose preoperative HbA1c levels were recorded in the hospital information system before the planned surgery, were considered. Patients who were diagnosed with type 2 DM, whose HbA1c levels were measured preoperatively, who underwent elective major ABSTRACT Objective: To investigate the relationship between the preoperative HbA1c levels and the complications and mortality rates in the postoperative period in patients with diabetes undergoing a major surgical treatment. Methodology: Diabetic patients, who underwent major surgery (a large resection) having preoperative HbA1c levels, were considered. A total of 1,013 patients, whose file data were completely accessed, were included in the study. Preoperative HbA1c levels of the patients and complications seen within the first 7 and first 30 days postoperatively were recorded. Results: Fourty-nine (4.8%) of the patients were exitus in the hospital, while 964 (95.2%) of the patients were discharged. Preoperative HbA1c levels of the patients were found to be predictive marker of mortality and complications in the first 7 and 30 days postoperatively (p <0.001). Conclusion: HbA1c levels are important in preoperative surgical risk assessment in diabetic patients. Better provision of long-term glycemic control in patients planned elective surgery and have low levels of HbA1c may significantly reduce postoperative mortality and complications.
INTRODUCTION
Diabetes is a complex and chronic disease that requires continuous medical care with a multi-factor risk reduction strategy based on glycemic control. 1 Major surgery is any invasive operation that includes a large resection. Chronic complications of diabetes are secondary conditions that occur later and cause serious problems. Chronic complications of diabetes can be prevented or delayed by good glycemic control. These chronic complications of diabetic patients can also affect major surgical outcomes. One of the two parameters showing glycemic control in diabetic patients is the plasma glucose level, while the other is the glycolated hemoglobin (HbA1c) level. High HbA1c values are particularly associated with increased complications associated with microvascular and cardiovascular diseases. 2 According to the American Diabetes Association (ADA) 2017 guidelines, the target glycemic control index is considered to be below 7% (53 mmol/mol) of HbA1c in non-pregnant adult diabetic patients. 3 There are limited number of studies reporting the cut-off level value of HbA1c to predict mortality and complications in patients undergoing major surgery.
In this study, the aim was to determine the cut-off value of HbA1c levels in adult diabetic patients undergoing major surgery surgery, were over 18 years of age, hemoglobin levels above 10 mg/dl and had complete file history, were included in the study. Patients with diabetes other than type 2 DM, under 18 years of age, who underwent emergency major surgery, patients with chronic liver disease, patients with chronic renal failure, patients whose data files were inaccessible or incomplete, hemoglobin levels under 10 mg/dl, and those without preoperative HbA1c values, were excluded from the study.
The age, comorbid diseases, history of surgery were recorded on the study form from the patients' files. Hemoglobin, hematocrit, white blood cell count, thrombocyte count, fasting blood glucose, blood urea nitrogen, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), sodium, potassium and HbA1c values were recorded from the laboratory before the operation. The epicrisis forms of the patients recorded their diagnosis, type and group of operation, duration of postoperative ward and/or intensive care admission, outcome within the first 7 and first 30 days after the operation. The complications of the patients who developed complications, were recorded.
Additionally, the patients were divided into four groups. Group 1 included patients with HbA1c levels below 7%. Group 2 included patients with HbA1c levels between 7% and 7.99%. Group 3 included patients with HbA1c levels between 8% and 8.99%. Group 4 included patients with HbA1c levels more than 9%. The mortality and complications seen in the first 7 and 30 days between groups were compared. SPSS 15 package programme was used for the statistical evaluation of the data obtained in the study (SPSS Inc, Chicago, Illinois, USA). Continuous data were summarised as mean, standard deviation, while categorical data were summarised as number and percentage. The receiver operating characteristic (ROC) curve was used to investigate the accuracy of HbA1c in measuring the complications and mortalities. The criterion for best test definition according to this method was accepted as the sensitivity 100%, the false positivity of zero (1-specificity = 0), the area under the curve (AUC) as 1 and the diagnostic value of AUC as p<0.05. When the cut-off value was determined, the highest sensitivity in the ROC curve and the Youden index of the specificity point were used. Sensitivity, specificity parameters were presented as a table with 95% confidence interval.
RESULTS
A total of 1,013 patients were included in the study; while 484 (47.8%) of the patients were females and 529 (52.2%) were males. The mean age of the patients was 55.88 ±12.634 years. As for the indication of major surgery, 45.7% (n=463) cardiovascular diseases were found to be the most frequently operated group. Malignant tumors were second with 18.9% (n = 191) and obesity surgeries were third with 16.1% (n = 163).
When the complication rates of the patients were examined within the first 7 days, 868 patients (85.7%) had no complications and 113 patients (11.2%) had complications. A total of 32 patients (3.2%) died during this period. When the patients were examined according to complication, wound infection (N = 24, 2.4%) was the most common. When the complication rates of the patients were examined within the first 30 days, 806 patients (79.6%) had no complications and 159 patients (15.7%) had complications. A total of 48 patients (4.7%) died during this period. When the patients were examined according to complication, wound infection (n=60, 5.9%) was the most common (Table I) .
ROC analyses were performed for the role of preoperative HbA1c values of patients in predicting deaths within the first 7 days and within the first 30 days. Within the first 7 days, the area under the curve was found to Table II ). Area under the curve for the prediction of mortality within the first 30 days was found to be 0.607 (95% confidence interval, in the 52.7-68.7 interval, p<0.012, Table II ).
ROC analyses were performed for the role of preoperative HbA1c values in predicting the occurrence of complications in the first 7 days and first 30 days. The area under the curve was found to be 0.653 (95% confidence interval, in the 60.7-69.8 interval, p<0,001) in the measurements made in determining the complications within the first 7 days (Table II) .
The area under the curve was found to be 0.785 (95% confidence interval, in the 75.1-82.0 interval, p<0.001) in the measurements made in determining the complications within the first 30 days. When the cut-off value of HbA1c was 7.45%, sensitivity was 63.8% and specificity was 78.8% (Table II) .
ROC analyses were performed to determine role of preoperative HbA1c levels in predicting the presence of wound infection in the first 7 days and first 30 days. In the measurements made within the first 7 days for determining wound infection, the area under the curve was found to be 0.737 (95% confidence interval, in the 66.1 -81.2 interval, p<0,001). When the cut-off value of HbA1c was 7.65%, sensitivity was 53.3% and specificity was 73.3% (Table II) .
In the measurements made within the first 30 days for determining wound infection, the area under the curve was found to be 0.788 (95% confidence interval, in the 73.8 -83.9 interval, p<0.001). When the cut-off value of HbA1c was 7.85%, sensitivity was 65.0% and specificity was 77.1% (Table II) .
ROC analyses were performed to determine role of preoperative HbA1c levels in predicting the presence of total infection in the first 7 days and first 30 days. In the measurements made within the first 7 days for determining total infection, the area under the curve was found to be 0.668 (95% confidence interval, in the 60.1 -73.5 interval, p<0.0001, Table II ).
In the measurements made within the first 30 days for determining total infection, the area under the curve was found to be 0.815 (95% confidence interval, in the 78.0 -85.1 interval, p<0.0001). When the cut-off value of HbA1c was 7.45%, sensitivity was 71.5% and specificity was 76.6% (Table II) .
DISCUSSION
HbA1c has been used for years in diabetic patients' follow-up; and in recent years, it has become a test used to diagnose diabetes. 3 Regulation of preoperative fasting blood glucose levels of patients scheduled for surgery is a known practice. However, even if the fasting blood sugar is regulated, the effect of long-term glycemic control is not clear. There are a limited number of studies on this topic. This work on long-term blood glucose regulation and the complications occuring in patients undergoing major surgical procedures, it was found that preoperative HbA1c measures can be an indicator of the incidence of mortality, complications, wound infection and total infection.
Zhong and colleagues documented a total of 32 researches, including cohort and meta-analysis studies. While the results of three studies showed the association of mortality with HbA1c in oncologic surgery patients was not significant. There was a significant correlation between the results of 6 studies examining mortality in patients undergoing cardiovascular surgery and the results of 11 investigators studying its relationship with all deaths. 4 Although there was no statistically significant difference among groups for the first 7 and first 30 days mortality in present study, when the ROC analysis of the relationship between the mortality rate in the first 7 days and first 30 days with HbA1c elevation was examined by ROC analysis, the mortality prediction was more significantly higher. According to these results, HbA1c levels might be a predictor marker for predicting postoperative mortality.
High HbA1c levels (>7%) are associated with higher incidence of micro-and macro-vascular complications in patients with type 2 DM. 5, 6 Many studies have shown that complications such as postoperative infections, [7] [8] [9] [10] [11] wound-related complications, 12, 13 and deep venous thrombosis 14 are more common in diabetic patients than in non-diabetic patients. HbA1c serves as a primary determinant of long-term complications of DM, and fasting blood glucose measurements serve as determinants of short-term complications. These two measurements are complementary because while intervening stress factors can affect fasting blood sugar, HbA1c is unaffected by this. 15, 16 HbA1c was an important predictor of all postoperative complications. Neuronal, vascular, cardiac damage, which are caused by diabetes in patients with uncontrolled chronic glycemia, perioperative anesthetic agent use and additional serious effects of these agents, may be a cause of these complications. Long-term high blood sugar exposure in diabetic patients results in tissue-level glycolysis without micro-or macro-vascular complications becoming obvious. This damage may prepare the ground for the development of various complications in high stress situations such as major surgery.
There are many studies investigating the role of HbA1c in predicting postoperative wound infection in diabetic patients in different surgical groups. Han and colleagues used HbA1c levels in association with glycemic control with arthroplasty surgery in diabetic patients. The results obtained indicate that there is a significant increase in the risk of wound infection in the patient group with a HbA1c level of 8% or more. 12 Another study with cardiac surgery reported that patients with HbA1c >8% had twice as many wound infections and this difference was statistically significant. 17 Gatti et al. evaluated the effect of HbA1c level in determining the risk of sternal wound infection with HbA1c in patients undergoing coronary surgery. In patients with HbA1c levels over 8.6%, the risk of serious sternal wound infection has been implicated and the importance of detecting preoperative HbA1c levels was stressed. As a result of the multivariate analysis they conducted, they also suggested that HbA1c is one of the strongest predictors of sternal wound infection. 18 According to the results of our study, the increase in HbA1c levels was associated with wound infection, total infection and other complications. Due to this results, preoperative HbA1c levels might be independent and powerful predictor for predicting postoperative wound infection, total infection and other complications. There are a number of factors that affect the appearance of infection at higher levels in patients with uncontrolled glycemia prior to surgery. These include genetic susceptibility, impaired cellular and humoral immune defence mechanisms, local factors such as reduced blood flow and neuropathy, and degenerations that occur in the regulation of collagen synthesis. 19, 20 Preoperative evaluation and reduction of postoperative complications and mortality in diabetic patients undergoing major surgery are very important. For this purpose, it is recommended that patients' fasting blood sugar level is regulated in routine practice. However, HbA1c values can be used effectively in the preliminary view of postoperative complications and mortality risk.
Better maintenance of long-term glycemic control in patients with elective surgery and high HbA1c levels may significantly reduce postoperative mortality and complications. In particular, cut-off values in terms of preoperative prediction of wound infection, pneumonia, and total infection burden were determined. It is anticipated that detection of patients with values above the cut-off values of HbA1c obtained before operation and lowering the HbA1c levels of these patients to below the cut-off value may seriously reduce postoperative wound infection, pneumonia and total infection burden.
This study was planned retrospectively. A number of genetic and acquired conditions, as well as drugs, may interfere with HbA1c levels and cause inappropriately high or low HbA1c measurements, were not included in this study.
CONCLUSION
Blood glucose level, and perioperative blood glucose monitoring and control are important in the preoperative period; but it is also important to determine whether or not long term glycemic control is optimal. Therefore, we think that it may be safer to maintain HbA1c values within normal limits in patients undergoing major surgery.
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